Slim Jim beef jerky maker Conagra Brands said on Thursday it may consider changing portion sizes of its snacks if the rising use of weight-loss drugs results in changes to food consumption patterns. Drugs such as Wegovy and Ozempic belong to a class of drugs known as GLP-1 agonists that were developed to treat type 2 diabetes, but also mimic a gut hormone that suppresses appetite and promotes a feeling of fullness. Sales of these drugs are soaring, leading to questions about whether greater consumer focus on weight loss could dampen sales for snack producers such as Nestle, Mondelez Internat...